seed
Stage
2
Investors
About
Mindmore develops digital neurocognitive tests, including The Minnemera service, a diagnostic tool initially aimed at primary and inpatient care.
Explore Mindmore's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.